In the present study, COVID-19 (+) patient plasma showed normal ADAMTS13 functional activity (≥50%) and normal platelet levels (~250 × 109/L), consistent with prior studies of COVID-19 disease progression and severity (10, 13). This evidence concerns the gene ADAMTS13 and COVID-19.